Monkeypox: A re-emerging disease

Indian J Pharmacol. 2024 Mar 1;56(2):129-135. doi: 10.4103/ijp.ijp_156_23. Epub 2024 Apr 30.

Abstract

The virus known as monkeypox is the source of the zoonotic disease monkeypox, which was historically widespread in Central Africa and West Africa. The cases of monkeypox in humans are uncommon outside of West and Central Africa, but copious nonendemic nations outside of Africa have recently confirmed cases. People when interact with diseased animals, then, they may inadvertently contact monkeypox. There are two drugs in the market: brincidofovir and tecovirimat and both of these drugs are permitted for the cure of monkeypox by the US Food and Drug Administration. The present review summarizes the various parameters of monkeypox in context with transmission, signs and symptoms, histopathological and etiological changes, and possible treatment. Monkeypox is clinically similar to that of smallpox infection but epidemiologically, these two are different, the present study also signifies the main differences and similarities of monkeypox to that of other infectious diseases. As it is an emerging disease, it is important to know about the various factors related to monkeypox so as to control it on a very early stage of transmission.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents* / therapeutic use
  • Benzamides / therapeutic use
  • Communicable Diseases, Emerging* / epidemiology
  • Cytosine / analogs & derivatives*
  • Cytosine / therapeutic use
  • Humans
  • Isoindoles / therapeutic use
  • Monkeypox virus
  • Mpox (monkeypox)* / epidemiology
  • Mpox (monkeypox)* / transmission
  • Organophosphonates / therapeutic use
  • Organothiophosphorus Compounds
  • Phthalimides*

Substances

  • Antiviral Agents
  • Cytosine
  • tecovirimat
  • brincidofovir
  • Isoindoles
  • Organothiophosphorus Compounds
  • Organophosphonates
  • Benzamides
  • Phthalimides